FDA-approved Drug Library

Catalog No. L4200

All compounds in FDA approved drug library have well-characterized biological activity, clear targets, safety, and bioavailability – properties which could dramatically accelerate drug development and optimization. It is an effective and ideal tool for drug repurposing and cell differentiation induction. Detailed information on each compound in this library can help scientists quickly finish drug screening or make quick judgement on cell differentiation mechanism, and create conditions for further investigation on the mechanism of action.

Pack Size	Price
100 μL * 10 mM (in DMSO)	USD 6820.00
250 μL * 10 mM (in DMSO)	USD 13410.00
1 mg	USD 13410.00

Product Description

A unique collection of 1364 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);
Bioactivity and safety confirmed by pre-clinical research evidence and clinical trials;
An effective tool for discovering new with old drugs and new drug target identification;
Covers various research areas: oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc
Structurally diverse, medicinally active, and cell permeable;
Rich documentation with structure, target, IC50 value and biological activity description;
NMR and HPLC/LCMS validated to ensure high purity.

The compound library can be highly customized. You can select compounds, quantities, format (dry/solid or DMSO), plate map, and concentration to meet your specific requirement. Please check our Compound Library Instructions for more information.

Packaging and Storage

Powder or pre-dissolved DMSO solutions in 96 well plate with optional 2D barcode
Shipped with dry ice.

Library Composition

Most Related Compound Categories